CTMX
CytomX Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.76
−2.13%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 22.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.99x
- Price / sales
- 32.86x
- Price / cash flow
- -7.30x
Enterprise value
- Enterprise value
- $276.8M
- EV / sales
- 15.13x
- EV / EBITDA
- -3.54x
- EV / EBIT
- -3.18x
- Market cap
- $601.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026